Startup profile · funding coverage
Function Health
Membership-based preventive health platform offering comprehensive lab testing and medical intelligence.
Stage
series b
Status
private
Coverage
full
Why Function Health is interesting
Function Health hit a $2.5B valuation on rapid consumer lab-testing growth; a16z backed from Series A with Redpoint leading the 2025 Series B.
Key facts
- Series B (2025): $298M led by Redpoint Ventures (/fund/redpoint-ventures) with a16z (/fund/andreessen-horowitz), Battery Ventures (/fund/battery-ventures), and Menlo Ventures (/fund/menlo-ventures) (TechCrunch)
- Series A (2024): $53M led by a16z (company announcement); reported $2.5B valuation at Series B
Investors in our directory
Funds linked from Function Health's profile — open a fund page for stage focus and related deal articles.
Industries
Healthtech Consumer
Industry hub pages are rolling out from our fund-derived baseline taxonomy.
FAQs about Function Health
Funding context and why this company shows up in venture coverage.
Function Health offers a membership-based preventive health service with comprehensive lab testing, biomarker tracking over time, and clinician-reviewed insights — aimed at consumers seeking proactive health data.
Function Health's $298M Series B (2025) was led by Redpoint Ventures (/fund/redpoint-ventures) with Andreessen Horowitz (/fund/andreessen-horowitz), Battery Ventures (/fund/battery-ventures), and Menlo Ventures (/fund/menlo-ventures). a16z led the prior $53M Series A (2024).
Function Health is at Series B based on its 2025 $298M round at a reported $2.5B valuation.
Direct-to-consumer lab testing is accelerating as consumers demand more health data. Function bundles broad panels with longitudinal tracking — a wedge into preventive care outside traditional insurance workflows.
No. Function Health remains a private company.
Last updated: 2026-07-24